Australian developer Currus Bio predicts that automating the production of its candidate cancer cell therapy, CUR-001, using the Cocoon platform will reduce costs and enhance its ability to scale production as the product moves through trials. The post Automation a Path to Lower Cell Therapy Costs appeared first on GEN - Genetic Engineering and Biotechnology News .

This is a summary of the story. Read the full article at GEN — Genetic Engineering & Biotechnology News ↗